Pelvic cancers Cancer Malignant neoplasm of other or ill-defined sites
Conditions
Interventions
Randomised test intervention versus no intervention controls, non-blinded Phase III
Sponsors
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Eligibility
Inclusion criteria
Inclusion criteria: 102 RMH patients, with a diagnosis of gynaecological or urological malignancy. Will be undergoing a course of radical or adjuvant pelvic radiotherapy to a curative dose (including patients undergoing concomitant chemotherapy).
Exclusion criteria
Exclusion criteria: 1. Patients with condition precluding oral nutrition 2. Patients undergoing conformal radiotherapy or intra-cavity brachytherapy 3. Patients with clotting disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess bowel toxicity using IBDQ and to assess whether there are differences in the score in patients in their intervention arm and the control. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed